$0.6084
-0.11-15.51%
Last update: Nov 12, 12:05 PM
Imunon Inc
IMNNNASDAQ
Imunon fell 81.8% from $3.95 to $0.72, behind the S&P 500's +11.2%. Its worst day was Oct 27 (−28.8%), and its low came Nov 11 at $0.72.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-1.16 beat the $-1.79 estimate on $0.00 revenue.
+5.3% · S&P 500 −1.7%
Story events cover the past 12 months · Times ET
Dear Valued Shareholders,2025, A Year of Momentum: Advancing Toward a Potential Breakthrough in Ovarian Cancer TreatmentAs we close out 2025, I am excited to reflect on a year marked by significant clinical progress,
+15.2% · S&P 500 −0.4%
EPS of $-1.30 beat the $-1.66 estimate on $0.00 revenue.
+2.1% · S&P 500 +2.9%
EPS of $-0.84 beat the $-1.22 estimate on $0.00 revenue.
−1.1% · S&P 500 −0.2%
EPS of $-0.54 beat the $-0.92 estimate on $0.00 revenue.
−1.2% · S&P 500 −0.3%
Imunon shares fell 28.8%, while the S&P 500 rose 0.6%.
−28.8%, the year's worst day · S&P 500 +0.6%
Where it ended: a close of $0.72 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.56).
Nothing in the past 12 months.
All IMNN dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for IMNN and SPY from Benzinga historical bars. Not investment advice.
